- Previous Close
11.74 - Open
11.74 - Bid 11.74 x --
- Ask 12.30 x --
- Day's Range
11.74 - 11.74 - 52 Week Range
9.80 - 21.38 - Volume
8,000 - Avg. Volume
31,027 - Market Cap (intraday)
50.87M - Beta (5Y Monthly) -0.33
- PE Ratio (TTM)
5.93 - EPS (TTM)
1.98 - Earnings Date May 30, 2025 - May 31, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Dr Lalchandani Labs Limited provides diagnostic and related healthcare tests and services in India. The company offers doctor consultation, pathology, radiology, hospital lab management, corporate health checkup, and blood bank services, as well as X-ray, TMT, ultrasound, 2D-echo, medical fitness examinations, etc. It also offers its products online. The company serves individual patients, hospitals and other healthcare providers, and corporate customers. Dr Lalchandani Labs Limited was founded in 1986 and is based in New Delhi, India.
www.lalchandanipathlab.comRecent News: DLCL.BO
View MorePerformance Overview: DLCL.BO
Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DLCL.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DLCL.BO
View MoreValuation Measures
Market Cap
50.87M
Enterprise Value
58.96M
Trailing P/E
5.93
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.20
Price/Book (mrq)
0.52
Enterprise Value/Revenue
1.40
Enterprise Value/EBITDA
3.29
Financial Highlights
Profitability and Income Statement
Profit Margin
20.37%
Return on Assets (ttm)
-0.61%
Return on Equity (ttm)
9.26%
Revenue (ttm)
42.09M
Net Income Avi to Common (ttm)
8.57M
Diluted EPS (ttm)
1.98
Balance Sheet and Cash Flow
Total Cash (mrq)
28.21M
Total Debt/Equity (mrq)
37.45%
Levered Free Cash Flow (ttm)
10.23M